Cano Health, Inc.
Healthcare · Services-Offices & Clinics of Doctors of Medicine · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
| Revenue | $3.14B | $2.74B | $1.61B | $831.6M | $361.4M |
| Operating income | −$1.00B | −$436.8M | −$135.2M | −$240,000 | −$9.7M |
| Net income | −$594.4M | −$207.3M | −$18.0M | −$2.9M | −$5,288 |
| Total assets | $1.01B | $1.93B | $2.14B | $614.2M | $45,568 |
| Total liabilities | $1.55B | $1.43B | $1.34B | $564.6M | $50,856 |
| Equity | −$348.0M | $252.6M | $318.7M | $49.6M | −$5,288 |
| EPS (diluted) | $-242.60 | $-0.95 | $-0.28 | — | — |
| Shares out. | 4.5M | 219.2M | 475.7M | — | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −32.0%
- Net margin
- −18.9%
- Return on equity
- 170.8%
- Return on assets
- −58.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 152.8%
- Debt / equity
- —
- Book value / share
- $-76.82
- Revenue growth (YoY)
- 14.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -17.70distress
- Accruals / assets
- −45.9%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 18, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 10, 2023
- NT 11-Kmissed a reporting deadline ↗Apr 3, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 2, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 2, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Nut Tree Capital Management, Lp10% owner | Jun 28, 2024 | J | 912,538 | — |
| Rivera Kim MDirector | Jun 28, 2024 | D | 2,485 | — |
| Armstrong David JOfficer — See remarks | Jun 28, 2024 | D | 6,641 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Bankruptcy or receivership · New financial obligation · Unregistered equity sale · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosure · Other material eventJul 1, 2024
- Regulation FD disclosureJun 28, 2024
- Regulation FD disclosureJun 21, 2024
- Regulation FD disclosureJun 17, 2024
- Other material eventJun 4, 2024
- Regulation FD disclosureMay 22, 2024
- Regulation FD disclosureMay 21, 2024
- Regulation FD disclosureMay 17, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.